Literature DB >> 22977456

Cardiac sarcoidosis presenting with complete atrioventricular block and sustained monomorphic ventricular tachycardia.

Joo Myung Lee1, Il-Young Oh, Dong-Ju Choi.   

Abstract

Sarcoidosis is a rare but potentially fatal multisystem granulomatous disease of unknown etiology. While a number of clinical manifestations may develop, cardiac involvement (prior to or coincident with sarcoidosis of other organs) is an important prognostic factor. Recently, we encountered a patient with cardiac sarcoidosis who presented with complete atrioventricular (AV) block and sustained ventricular tachycardia. An implantable cardioverter-defibrillator was inserted as a precautionary measure for ventricular tachycardia and symptomatic complete AV block. (18)F-fluoro-2-deoxyglucose positron emission tomography confirmed a dramatic response to high-dose steroid at four weeks, as demonstrated by a marked decrease in cardiac sarcoid activity from baseline status.

Entities:  

Keywords:  Heart failure; Magentic resonance imaging; Sarcoidosis; Tachycardia, ventricular

Year:  2012        PMID: 22977456      PMCID: PMC3438270          DOI: 10.4070/kcj.2012.42.8.571

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  17 in total

Review 1.  Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

Authors:  W C Roberts; H A McAllister; V J Ferrans
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

2.  The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.

Authors:  C J Johns; T M Michele
Journal:  Medicine (Baltimore)       Date:  1999-03       Impact factor: 1.889

Review 3.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

4.  Cardiac sarcoidosis: a retrospective study of 41 cases.

Authors:  Catherine Chapelon-Abric; Dominique de Zuttere; Pierre Duhaut; Pierre Veyssier; Bertrand Wechsler; Du Le Thi Huong; Christian de Gennes; Thomas Papo; Olivier Blétry; Pierre Godeau; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

5.  Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy.

Authors:  K Takada; Y Ina; M Yamamoto; T Satoh; M Morishita
Journal:  Sarcoidosis       Date:  1994-09

Review 6.  Cardiac sarcoidosis.

Authors:  Jessica S Kim; Marc A Judson; Robert Donnino; Michael Gold; Leslie T Cooper; Eric N Prystowsky; Stephen Prystowsky
Journal:  Am Heart J       Date:  2008-11-12       Impact factor: 4.749

7.  Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.

Authors:  B Belhassen; A Pines; S Laniado
Journal:  Chest       Date:  1989-04       Impact factor: 9.410

8.  Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device.

Authors:  S L Winters; M Cohen; S Greenberg; B Stein; J Curwin; E Pe; J A Gomes
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

9.  Sarcoidosis: epidemiology and prognosis. A 15-year European study.

Authors:  G Hillerdal; E Nöu; K Osterman; B Schmekel
Journal:  Am Rev Respir Dis       Date:  1984-07

10.  Clinicopathological study of fatal myocardial sarcoidosis.

Authors:  Y Matsui; K Iwai; T Tachibana; T Fruie; N Shigematsu; T Izumi; A H Homma; R Mikami; O Hongo; Y Hiraga; M Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.